Sai Life Sciences Limited — Important, 06-06-2025: Updates

Sai Life Sciences clarified that its ESOP pool of 14.05 mn options, with potential dilution capped at 1.6%, aligns with disclosures and governance norms. The exercise price follows strict guidelines tied to past investments, avoiding deep discounts. Vesting is performance- and time-based, aiding talent retention. Appointment of Sivaramakrishnan Chittor as WTD & CFO ensures leadership continuity without cost increase; his pay is performance-linked and within approved limits.